Preparation method of newborn bovine bone marrow zymolyte health product tablet for promoting organism hematopoiesis and enhancing immunity

Abstract

The invention relates to the technical field of nutritional health products, and particularly relates to a preparation method of a newborn bovine bone marrow zymolyte health product tablet for promoting organism hematopoiesis and enhancing immunity. The preparation method comprises the following steps: preferably selecting newborn bull bone marrow in a natural cattle farm in Inner Mongolia, performing degreasing, performing enzymolysis by utilizing papain to obtain an enzymolysis product, performing filtering to remove impurities, performing liposome coating, and performing freeze drying to obtain bone marrow freeze-dried powder; mixing the bone marrow freeze-dried powder with auxiliary materials such as longan, Chinese wolfberry, oyster, kudzu vine root, vitamin c and ferrous gluconate toprepare a tablet health product; and selecting an ICR healthy mouse, continuously feeding low-iron feed and double distilled water for 4 weeks, detecting a blood item index and an immunity index, establishing an iron-deficiency anemia model, and feeding the tablet prepared in the previous step to the anemia model mouse every day. The result shows that the blood item index and the immunity index are detected after 4 weeks, the anemia phenomenon of the mouse is obviously improved, the immunity is obviously improved, and the health product has obvious effects of promoting organism hematopoiesisand enhancing organism immunity.

Description

technical field [0001] The invention relates to the technical field of nutraceuticals, in particular to a method for preparing a newborn bovine bone marrow enzymatic hydrolyzate health product tablet for promoting hematopoiesis and enhancing immunity. Background technique [0002] According to the statistics of the World Health Organization (WHO), there are about 3 billion people in the world with varying degrees of anemia, and tens of millions of people die each year due to various diseases caused by anemia. The probability of anemia in China is higher than that in Western countries. Women with anemia are significantly higher than men, and the elderly and children are higher than young and middle-aged people. The incidence of anemia in modern urban residents is increasing at a rate of 10% to 15% every year. [0003] In addition to nutritional anemia, according to the pathogenesis, it can be divided into: ① hematopoietic anemia: such as aplastic anemia; ② anemia caused by e...

AI Technical Summary

Problems solved by technology

For severe β-thalassemia, medium and high-volume blood transfusions should be given from an early stage to make the growth and development of the children close to normal and prevent bone lesions, but this method can easily lead to hemosiderosis; Amines, which can increase the excretion of iron from urine and feces, but cannot prevent the absorption of iron from the gastrointestinal tract. Occasionally, allergic reactions may occur. Long-term use can cause cataracts and long bone development disorders. Excessive doses can cause vision and hearing loss.

2. Surgical treatment: splenectomy, the curative effect of splenectomy on β-thalassemia intermediate is better, and the effect on severe β-thalassemia is poor

[0005] The above treatment methods all have certain limitations and cannot fundamentally solve the problem of bone marrow hematopoiesis. Bone marrow is a human hematopoietic tissue located in the bone cavity of long bones and is responsible for the production of red blood cells, white blood cells and platelets.

Images